Prognostic Impact of D2-40 Expression and BCL6 Gene Rearrangement in Diffuse Large B-Cell Lymphoma

被引:0
|
作者
Al-Sissi, A. A. [1 ]
Mourad, M. I. [1 ]
El-Sissy, N. A. [1 ]
Abd El-Aziz, S. M. [1 ]
Shalaby, A. A. [1 ]
机构
[1] Mansoura Univ, Mansoura, Egypt
来源
JOURNAL OF PATHOLOGY | 2013年 / 231卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [31] Indolent clinical behaviour of primary cutaneous diffuse large B-cell lymphoma, leg type, with double MYC and BCL6 gene rearrangement
    Rodriguez-Pinilla, Socorro Maria
    Santonja, Carlos
    Stewart, Peter
    Carvajal, Nerea
    McCafferty, Neil
    Manso, Rebeca
    Meizoso, Telma
    Caro Gutierrez, Maria Dolores
    Piris, Miguel Angel
    Gonzalez de Castro, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (03) : E83 - E86
  • [32] Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Sermer, David
    Bobillo, Sabela
    Dogan, Ahmet
    Zhang, Yanming
    Seshan, Venkatraman
    Lavery, Jessica A.
    Batlevi, Connie
    Caron, Philip
    Hamilton, Audrey
    Hamlin, Paul
    Horwitz, Steven
    Joffe, Erel
    Kumar, Anita
    Matasar, Matthew
    Noy, Ariela
    Owens, Colette
    Moskowitz, Alison
    Palomba, M. Lia
    Straus, David
    von Keudell, Gottfried
    Rodriguez-Rivera, Ildefonso
    Falchi, Lorenzo
    Zelenetz, Andrew
    Yahalom, Joachim
    Younes, Anas
    BLOOD ADVANCES, 2020, 4 (14) : 3382 - 3390
  • [33] Mef2b Expression Correlates with Bcl6 and Myc in Diffuse Large B Cell Lymphoma
    Chou, D. B.
    Chi, A.
    Siddiquee, Z.
    Kovach, A. E.
    Hasserjian, R. P.
    Sohani, A. R.
    Ryan, R. J. H.
    MODERN PATHOLOGY, 2014, 27 : 343A - 343A
  • [34] Mef2b Expression Correlates with Bcl6 and Myc in Diffuse Large B Cell Lymphoma
    Chou, D. B.
    Chi, A.
    Siddiquee, Z.
    Kovach, A. E.
    Hasserjian, R. P.
    Sohani, A. R.
    Ryan, R. J. H.
    LABORATORY INVESTIGATION, 2014, 94 : 343A - 343A
  • [35] Prognostic Significance of BCL6 Translocation in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.
    Shustik, Jesse
    Steidl, Christian
    Selm, Laurie
    Gascoyne, Randy D.
    BLOOD, 2008, 112 (11) : 1294 - 1295
  • [36] Strong Expression of D2-40 in Lymphoma-Associated Stroma Is Associated with Superior Outcome in Diffuse Large B-Cell Lymphoma
    Peker, D.
    Chang, C. C.
    Hagemeister, F.
    Zu, Y.
    Ewton, A.
    Curry, C.
    Jones, D.
    MODERN PATHOLOGY, 2009, 22 : 280A - 280A
  • [37] Strong Expression of D2-40 in Lymphoma-Associated Stroma Is Associated with Superior Outcome in Diffuse Large B-Cell Lymphoma
    Peker, D.
    Chang, C. C.
    Hagemeister, F.
    Zu, Y.
    Ewton, A.
    Curry, C.
    Jones, D.
    LABORATORY INVESTIGATION, 2009, 89 : 280A - 280A
  • [38] BCL2 and BCL6 atypical/unbalanced gene rearrangements in diffuse large B-cell lymphoma are indicators of an aggressive clinical course
    Tourneret, Alicia
    Alame, Melissa
    Rigau, Valerie
    Bauchet, Luc
    Fabbro, Michel
    De Oliveira, Laura
    Cacheux, Valere
    Costes, Valerie
    Lacheretz-Szablewski, Vanessa
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (10) : 650 - 656
  • [39] REARRANGEMENT OF THE BCL-6 GENE AS A PROGNOSTIC MARKER IN DIFFUSE LARGE-CELL LYMPHOMA
    OFFIT, K
    LOCOCO, F
    LOUIE, DC
    PARSA, NZ
    LEUNG, D
    PORTLOCK, C
    YE, BH
    LISTA, F
    FILIPPA, DA
    ROSENBAUM, A
    LADANYI, M
    JHANWAR, S
    DALLAFAVERA, R
    CHAGANTI, RSK
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (02): : 74 - 80
  • [40] Significance of rearrangement of the BCL6 gene in B-Cell lymphoid neoplasms
    Ohno, H
    Fukuhara, S
    LEUKEMIA & LYMPHOMA, 1997, 27 (1-2) : 53 - 63